Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKinsey
Harvard Business School
Boehringer Ingelheim
McKesson

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211469


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 211469 describes LIDOCAINE, which is a drug marketed by Acp Nimble, Aleor Dermaceuticals, Alkem Labs Ltd, Amneal Pharms, Belmora Llc, Fougera Pharms Inc, Glenmark Pharms Ltd, Novast Labs, Septodont Inc, Strides Pharma, Sungen Pharma, Taro, Teligent Pharma Inc, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Mylan Technologies, Fougera Pharms, Hi Tech Pharma, Tolmar, Abbott, Abraxis Pharm, Akorn, Aurobindo Pharma Ltd, B Braun Medical Inc, Bel Mar, Dell Labs, Elkins Sinn, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Luitpold, Lyphomed, Miles, Mylan Labs Ltd, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Watson Labs Inc, Wockhardt Bio Ag, Hikma, Lannett Co Inc, Paco, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, and Actavis Mid Atlantic, and is included in one hundred and eighteen NDAs. It is available from forty-one suppliers. Additional details are available on the LIDOCAINE profile page.

The generic ingredient in LIDOCAINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 211469
Tradename:LIDOCAINE
Applicant:Aleor Dermaceuticals
Ingredient:lidocaine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 211469
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for 211469
Suppliers and Packaging for NDA: 211469
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE lidocaine OINTMENT;TOPICAL 211469 ANDA Alembic Pharmaceuticals, Inc. 62332-424 62332-424-30 1 TUBE in 1 CARTON (62332-424-30) > 30 g in 1 TUBE
LIDOCAINE lidocaine OINTMENT;TOPICAL 211469 ANDA Alembic Pharmaceuticals, Inc. 62332-424 62332-424-35 1 TUBE in 1 CARTON (62332-424-35) > 35.44 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength5%
Approval Date:Nov 23, 2018TE:ATRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
Medtronic
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.